iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Mankind Pharma Ltd Option Chain

2,352.4
(-0.29%)
Jun 6, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--2,000₹2.35 -18.96%3,600-60%
--2,100₹6 -13.04%9,4502.43%
--2,150₹10 -23.07%5,4000%
--2,200₹15 -15.25%38,700-0.57%
4500%₹143.25 0%2,250₹25.25 -9.82%19,3500%
6,3001300%₹106.7 -2.95%2,300₹40 -8.88%74,250-0.30%
14,85046.66%₹76.85 -7.4%2,350₹58.5 -7.14%11,7001.96%
33,075-11.97%₹52.45 -13.8%2,400₹85.25 -6.31%36,675-5.78%
29,2502.36%₹35.05 -14.51%2,450₹130.25 0%1,3500%
61,2006.66%₹24.15 -12.65%2,500₹158 -5.38%9,4500%
12,825-5%₹15.8 -21%2,550--
1,30,5003.01%₹10.5 -23.07%2,600--
3,82530.76%₹7 -13.04%2,650--
31,275-2.79%₹5.2 -10.34%2,700--
9,90033.33%₹2.55 -10.52%2,800--
16,2009.09%₹2.1 13.51%2,900--

Mankind Pharma: Related NEWS

Mankind Pharma posts mixed performance in Q4; stock slips ~4%
22 May 2025|12:15 PM

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

Read More
Top Stocks for Today - 22nd May 2025
22 May 2025|06:38 AM

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand
30 Mar 2025|04:34 PM

The cumulative demand, including interest charges, is ₹183.11 crore.

Read More
Mankind Pharma Merges Three Subsidiaries
30 Mar 2025|01:33 PM

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal
28 Feb 2025|11:13 PM

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%
23 Jan 2025|11:57 PM

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV
8 Jan 2025|04:01 PM

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

Read More
Mankind Pharma, Innovent Join Forces for Cancer Care
26 Dec 2024|12:46 PM

According to the National Cancer Registry Programme, cancer is expected to cause 29.8 million DALYs by 2025, making it a serious health issue in India.

Read More
Mankind Pharma Secures ₹3,000 Crore via QIP for Growth
20 Dec 2024|02:06 PM

The issue price includes a premium of ₹2,519 per share, aggregating a total of ₹2,999.99 crore.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.